Electronic Journal of General Medicine

• Lee JC, Chow NH, Wang ST, Huang SM. Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients. Eur J Cancer 2000;36:748-53.
• Benson AB, Ajani JA, Catalano RB, et al. Recommended guide-lines for the treatment-induced diarrhea. J Clin Oncol 2004;22:2918-26.
• Graziono F, Cascinu S. Prognostic molecular markers for planning adjuvant chemotherapy trials in Dukes’B colorectal cancer patients: how much evidence is enough? Ann Oncol 2003;14:1026-38.
• Negri FV, Campanini N, Camisa R, et al. Biological predictive factors in rectal cancer treated preoperative radiotherapy or radiochemotherapy. Br J Cancer 2008;98: 143-7.
• Font A, Abad A, Monzo M, et al. Prognostic value K-ras mutations and allelic imbalance on chromosome 18q in patients with resected colorectal cancer. Dis Colon Rectum 2001;44:549-57.
• Jernvall P, makine Mj, Karttunen TJ, Makela J, et al. Loss of heterozygosity at 18q21 is a indicative of recurrence and therefore poor prognosis in a subset of colorectal cancers. Br J cancer 1999;79:903-8.
• Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 2004;25:581-611.
• Ivarsson ML, Bergstrom M, Eriksson E, Risberg B, et al. Tissue markers as predictors of postoperative adhesions. Br J Surg 1998;85:1549-54.
• Edler D, Glimelius B, Hallstrom M, et al. Thymidylate synthase expression in colorectal cancer: a prognostic and predictive marker of benefit from adjuvant fluorouracilbased chemotherapy. J Clin Oncol 2002; 20:1721-28.
• Kim JG, Chae YS, Sohn KS, et al. Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with colorectal cancer. Clin Cancer Res 2008;14:62-6.
• Stevens A, Soden J, Brenchley PE, Ralph S, Ray DW. Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter. Cancer Res 2003;63:812-6.
• Karayiannakis AJ, Syrigos KN, Zhar A, et al. Clinical significance of preoperative serum vascular endothelial growth factor levels in patients with colorectal cancer and the effect f tumor surgery. Surgery 2007;131:548-55.
• Kumar H, Heer K, Lee PW, et al. Preoperative serum Vascular endothelial growth factor can predict stage in colorectal cancer. Clin Cancer Res 1998;4:1279-85.
• Zlobec I, Steele R, Compton CC. VEGF as a predictive marker of rectal tumor response to preoperative radiotherapy. Cancer 2005;104:2517-21.
• Chin KF, Greenman J, Gardiner F, Kumar H, Topping K, Monson J. Pre-operative serum vascular endothelial growth factor can select patients for adjuvant treatment after curative resection in colorectal cancer. Br J Cancer 2000;83:1425-31.
• Tamura M, Oda M, Tsunezuka Y, Matsumoto I, Kawakami K, Watanabe G. Vascular endothelial growth factor expression in metastatic pulmonary tumor from colorectal carcinoma: utility as a prognostic factor. J Thorac Cardiovasc Surg 2004;128:517-22.
• Higashiyama A, Watanabe H, Okumura K, Yagita H. Involvement of tumor necrosis factor alpha and very late activation antigen 4/vascular cell adhesion molecule 1 interaction in surgical-stress-enhanced experimental metastases. Cancer Immunol Immunother 1996;42:231-6.
• Pigott R, Dillon LP, hemingway IH, Gearing AJ. Soluble forms of E-selectin, ICAM-1, and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem BİOPHYS Commun 1992;187:584-9.

Vancouver

Kemik Ö, Kemik AS, Hasırcı İ, Adaş M, Purisa S, Dülger AC, et al. Serum Level of Soluble Vascular Adhesion Molecule 1 in Patients with Rectal Cancer. EUR J GEN MED. 2011;8(2):105-9. https://doi.org/10.29333/ejgm/82709

APA

Kemik, Ö., Kemik, A. S., Hasırcı, İ., Adaş, M., Purisa, S., Dülger, A. C., & Tüzün, S. (2011). Serum Level of Soluble Vascular Adhesion Molecule 1 in Patients with Rectal Cancer. European Journal of General Medicine, 8(2), 105-109. https://doi.org/10.29333/ejgm/82709

AMA

Kemik Ö, Kemik AS, Hasırcı İ, et al. Serum Level of Soluble Vascular Adhesion Molecule 1 in Patients with Rectal Cancer. EUR J GEN MED. 2011;8(2), 105-109. https://doi.org/10.29333/ejgm/82709

Chicago

Kemik, Özgür, Ahu Sarbay Kemik, İsmail Hasırcı, Mine Adaş, Sevim Purisa, Ahmet Cumhur Dülger, and Sefa Tüzün. "Serum Level of Soluble Vascular Adhesion Molecule 1 in Patients with Rectal Cancer". European Journal of General Medicine 2011 8 no. 2 (2011): 105-109. https://doi.org/10.29333/ejgm/82709

Harvard

Kemik, Ö., Kemik, A. S., Hasırcı, İ., Adaş, M., Purisa, S., Dülger, A. C., and Tüzün, S. (2011). Serum Level of Soluble Vascular Adhesion Molecule 1 in Patients with Rectal Cancer. European Journal of General Medicine, 8(2), pp. 105-109. https://doi.org/10.29333/ejgm/82709

MLA

Kemik, Özgür et al. "Serum Level of Soluble Vascular Adhesion Molecule 1 in Patients with Rectal Cancer". European Journal of General Medicine, vol. 8, no. 2, 2011, pp. 105-109. https://doi.org/10.29333/ejgm/82709